Cas:106-55-8 2,5-Dimethylpiperazine manufacturer & supplier

We serve Chemical Name:2,5-Dimethylpiperazine CAS:106-55-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,5-Dimethylpiperazine

Chemical Name:2,5-Dimethylpiperazine
CAS.NO:106-55-8
Synonyms:2,4-DINITRO-5-FLUOROTOLUENE;2,5-dimethyl piperazine;2,5-trans-methylpiperazine;MFCD00005955;cis,trans-2,5-dimethylpiperazine;UNII-VZG2W7X75O;3,6-dimethylpiperazine;EINECS 203-409-4;cis-2,5-dimethyl piperazine;2,5-Dimethylpiperazine;Piperazine, 2,5-dimethyl-
Molecular Formula:C6H14N2
Molecular Weight:114.189
HS Code:2933599090

Physical and Chemical Properties:
Melting point:113-118ºC
Boiling point:165.9±8.0 °C at 760 mmHg
Density:0.8±0.1 g/cm3
Index of Refraction:1.413
PSA:24.06000
Exact Mass:114.115700
LogP:-0.19

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,4-DINITRO-5-FLUOROTOLUENE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Piperazine, 2,5-dimethyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cis-2,5-dimethyl piperazine Use and application,2,5-trans-methylpiperazine technical grade,usp/ep/jp grade.


Related News: “With our commercial capability, we will definitely make sure that we can stabilize and continue growing,” Wang said. N-(2,2-dimethyl-1-(phenylarsaneylidene)propyl)-1,1,1-trimethyl-N-phenylsilanamine manufacturers As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. Cα-methylleucine suppliers AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. 2(RS)-D-manno-(1′,2′,3′,4′,5′-pentahydroxypentyl)thiazolidine-4(R)-carboxylic acid vendor & factory.